La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Identifieur interne : 000062 ( Main/Exploration ); précédent : 000061; suivant : 000063

Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Auteurs : Michael G. Schlossmacher [Canada] ; Julianna J. Tomlinson [Canada] ; Goncalo Santos [Canada] ; Bojan Shutinoski [Canada] ; Earl G. Brown [Canada] ; Douglas Manuel [Canada] ; Tiago Mestre [Canada]

Source :

RBID : pubmed:27859866

Abstract

Fifty-five years after the concept of dopamine replacement therapy was introduced, Parkinson disease (PD) remains an incurable neurological disorder. To date, no disease-modifying therapeutic has been approved. The inability to predict PD incidence risk in healthy adults is seen as a limitation in drug development, because by the time of clinical diagnosis ≥ 60% of dopamine neurons have been lost. We have designed an incidence prediction model founded on the concept that the pathogenesis of PD is similar to that of many disorders observed in ageing humans, i.e. a complex, multifactorial disease. Our model considers five factors to determine cumulative incidence rates for PD in healthy adults: (i) DNA variants that alter susceptibility (D), e.g. carrying a LRRK2 or GBA risk allele; (ii) Exposure history to select environmental factors including xenobiotics (E); (iii) Gene-environment interactions that initiate pathological tissue responses (I), e.g. a rise in ROS levels, misprocessing of amyloidogenic proteins (foremost, α-synuclein) and dysregulated inflammation; (iv) sex (or gender; G); and importantly, (v) time (T) encompassing ageing-related changes, latency of illness and propagation of disease. We propose that cumulative incidence rates for PD (PR ) can be calculated in healthy adults, using the formula: PR (%) = (E + D + I) × G × T. Here, we demonstrate six case scenarios leading to young-onset parkinsonism (n = 3) and late-onset PD (n = 3). Further development and validation of this prediction model and its scoring system promise to improve subject recruitment in future intervention trials. Such efforts will be aimed at disease prevention through targeted selection of healthy individuals with a higher prediction score for developing PD in the future and at disease modification in subjects that already manifest prodromal signs.

DOI: 10.1111/ejn.13476
PubMed: 27859866


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.</title>
<author>
<name sortKey="Schlossmacher, Michael G" sort="Schlossmacher, Michael G" uniqKey="Schlossmacher M" first="Michael G" last="Schlossmacher">Michael G. Schlossmacher</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tomlinson, Julianna J" sort="Tomlinson, Julianna J" uniqKey="Tomlinson J" first="Julianna J" last="Tomlinson">Julianna J. Tomlinson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Santos, Goncalo" sort="Santos, Goncalo" uniqKey="Santos G" first="Goncalo" last="Santos">Goncalo Santos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Medicine, University of Ottawa, Ottawa</wicri:regionArea>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shutinoski, Bojan" sort="Shutinoski, Bojan" uniqKey="Shutinoski B" first="Bojan" last="Shutinoski">Bojan Shutinoski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Brown, Earl G" sort="Brown, Earl G" uniqKey="Brown E" first="Earl G" last="Brown">Earl G. Brown</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Manuel, Douglas" sort="Manuel, Douglas" uniqKey="Manuel D" first="Douglas" last="Manuel">Douglas Manuel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Medicine, University of Ottawa, Ottawa</wicri:regionArea>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mestre, Tiago" sort="Mestre, Tiago" uniqKey="Mestre T" first="Tiago" last="Mestre">Tiago Mestre</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27859866</idno>
<idno type="pmid">27859866</idno>
<idno type="doi">10.1111/ejn.13476</idno>
<idno type="wicri:Area/PubMed/Corpus">000088</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000088</idno>
<idno type="wicri:Area/PubMed/Curation">000088</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000088</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000088</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000088</idno>
<idno type="wicri:Area/Ncbi/Merge">002148</idno>
<idno type="wicri:Area/Ncbi/Curation">002148</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002148</idno>
<idno type="wicri:Area/Main/Merge">000062</idno>
<idno type="wicri:Area/Main/Curation">000062</idno>
<idno type="wicri:Area/Main/Exploration">000062</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.</title>
<author>
<name sortKey="Schlossmacher, Michael G" sort="Schlossmacher, Michael G" uniqKey="Schlossmacher M" first="Michael G" last="Schlossmacher">Michael G. Schlossmacher</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tomlinson, Julianna J" sort="Tomlinson, Julianna J" uniqKey="Tomlinson J" first="Julianna J" last="Tomlinson">Julianna J. Tomlinson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Santos, Goncalo" sort="Santos, Goncalo" uniqKey="Santos G" first="Goncalo" last="Santos">Goncalo Santos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Medicine, University of Ottawa, Ottawa</wicri:regionArea>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shutinoski, Bojan" sort="Shutinoski, Bojan" uniqKey="Shutinoski B" first="Bojan" last="Shutinoski">Bojan Shutinoski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Brown, Earl G" sort="Brown, Earl G" uniqKey="Brown E" first="Earl G" last="Brown">Earl G. Brown</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Manuel, Douglas" sort="Manuel, Douglas" uniqKey="Manuel D" first="Douglas" last="Manuel">Douglas Manuel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Medicine, University of Ottawa, Ottawa</wicri:regionArea>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mestre, Tiago" sort="Mestre, Tiago" uniqKey="Mestre T" first="Tiago" last="Mestre">Tiago Mestre</name>
<affiliation wicri:level="1">
<nlm:affiliation>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Neuroscience Program, Ottawa Hospital Research Institute, 451 Smyth Road, RGH #1414, Ottawa, ON, K1H 8M5</wicri:regionArea>
<wicri:noRegion>K1H 8M5</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The European journal of neuroscience</title>
<idno type="eISSN">1460-9568</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Fifty-five years after the concept of dopamine replacement therapy was introduced, Parkinson disease (PD) remains an incurable neurological disorder. To date, no disease-modifying therapeutic has been approved. The inability to predict PD incidence risk in healthy adults is seen as a limitation in drug development, because by the time of clinical diagnosis ≥ 60% of dopamine neurons have been lost. We have designed an incidence prediction model founded on the concept that the pathogenesis of PD is similar to that of many disorders observed in ageing humans, i.e. a complex, multifactorial disease. Our model considers five factors to determine cumulative incidence rates for PD in healthy adults: (i) DNA variants that alter susceptibility (D), e.g. carrying a LRRK2 or GBA risk allele; (ii) Exposure history to select environmental factors including xenobiotics (E); (iii) Gene-environment interactions that initiate pathological tissue responses (I), e.g. a rise in ROS levels, misprocessing of amyloidogenic proteins (foremost, α-synuclein) and dysregulated inflammation; (iv) sex (or gender; G); and importantly, (v) time (T) encompassing ageing-related changes, latency of illness and propagation of disease. We propose that cumulative incidence rates for PD (PR ) can be calculated in healthy adults, using the formula: PR (%) = (E + D + I) × G × T. Here, we demonstrate six case scenarios leading to young-onset parkinsonism (n = 3) and late-onset PD (n = 3). Further development and validation of this prediction model and its scoring system promise to improve subject recruitment in future intervention trials. Such efforts will be aimed at disease prevention through targeted selection of healthy individuals with a higher prediction score for developing PD in the future and at disease modification in subjects that already manifest prodromal signs.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Schlossmacher, Michael G" sort="Schlossmacher, Michael G" uniqKey="Schlossmacher M" first="Michael G" last="Schlossmacher">Michael G. Schlossmacher</name>
</noRegion>
<name sortKey="Brown, Earl G" sort="Brown, Earl G" uniqKey="Brown E" first="Earl G" last="Brown">Earl G. Brown</name>
<name sortKey="Manuel, Douglas" sort="Manuel, Douglas" uniqKey="Manuel D" first="Douglas" last="Manuel">Douglas Manuel</name>
<name sortKey="Mestre, Tiago" sort="Mestre, Tiago" uniqKey="Mestre T" first="Tiago" last="Mestre">Tiago Mestre</name>
<name sortKey="Santos, Goncalo" sort="Santos, Goncalo" uniqKey="Santos G" first="Goncalo" last="Santos">Goncalo Santos</name>
<name sortKey="Shutinoski, Bojan" sort="Shutinoski, Bojan" uniqKey="Shutinoski B" first="Bojan" last="Shutinoski">Bojan Shutinoski</name>
<name sortKey="Tomlinson, Julianna J" sort="Tomlinson, Julianna J" uniqKey="Tomlinson J" first="Julianna J" last="Tomlinson">Julianna J. Tomlinson</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000062 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000062 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27859866
   |texte=   Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27859866" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022